1st Quarter - Report — SIEMENS MEDICAL SOLUTIONS USA, INC for SIEMENS MEDICAL SOLUTIONS USA, INC (2021)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

SIEMENS MEDICAL SOLUTIONS USA, INC

Client

SIEMENS MEDICAL SOLUTIONS USA, INC

Income

—

Expenses

$450,000

Expense method

C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
1st Quarter - Report (this page)	Apr 20, 2021	$450,000	Replaced
1st Quarter - Amendment	Jul 20, 2021	$450,000	Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

- Government Procurement Agreement, Buy America - Exports of human sourced and animal sourced material to China - US Department of Agriculture, Animal Plant and Health Inspection Service (APHIS), the US Department of Commerce, the US Food and Drug Administration - Presidents Executive Order on Supply Chain and Rare Earth

Lobbyist	Covered position, as disclosed
MARK ESHERICK	—
ELEANOR WENNER KERR	—

Contacted: SENATE; Commerce, Dept of (DOC); Food & Drug Administration (FDA); Homeland Security, Dept of (DHS); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES

Health Issues HCR

- H.R. 2009, Removing Barriers to Allergy Diagnostic Testing; S. 2246 Allergy Testing Access Act of 2019 - equal coverage of initiative specific immunoglobulin tests and percutaneous tests for allergies under Medicaid and Medicare Programs - H.R. 6102 - Verifying Accurate Leading-Edge IVCT Development Act - modernize regulation of -clinical laboratory tests - COVID-19 testing in congregate settings, schools, businesses. - Utility of serology testing and vaccine rollouts - Regulate independent device service businesses - Medicare reimbursement for diagnostic radiopharmaceuticals in the Hospital Outpatient Department - Regulation and coverage and payment for imaging artificial intelligence - Medical device user fees

Lobbyist	Covered position, as disclosed
MARK ESHERICK	—
ELEANOR WENNER KERR	—

Contacted: Food & Drug Administration (FDA); Commerce, Dept of (DOC); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; SENATE; Homeland Security, Dept of (DHS)

Bills named: H.R. 2009 (117th), S. 2246 (117th), H.R. 6102 (117th)

Budget/Appropriations BUD

- American Rescue Plan - funding for expanding COVID-19 testing, lab and hospital infrastructure, surveillance

Lobbyist	Covered position, as disclosed
MARK ESHERICK	—
ELEANOR WENNER KERR	—

Contacted: Homeland Security, Dept of (DHS); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Agriculture, Dept of (USDA)

Homeland Security HOM

- Cybersecurity requirements for critical infrastructure. - Legacy imaging equipment and cybersecurity - National Interest Waiver program for essential workers entering the U.S. - US Department of Homeland Security

Lobbyist	Covered position, as disclosed
MARK ESHERICK	—
ELEANOR WENNER KERR	—

Contacted: Commerce, Dept of (DOC); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.